AAI/CML Invests in DE Dietrich Agitated Filter Dryer
News Dec 29, 2015
AAIPharma Services Corp. / Cambridge Major Laboratories, Inc. (AAI/CML) have announced that it has upgraded its small molecule manufacturing capabilities at its site in Weert, Netherlands with the installation of a DE Dietrich Agitated Filter Dryer for controlled isolation of Intermediates and Active Pharmaceutical Ingredients (APIs).
The filter dryer, first introduced early this year, provides a completely closed system unit for isolation and drying, which minimizes operator exposure and provides a safer manufacturing environment.
“The investment in this technology has improved containment around isolation, enhanced the safety of our operating environment, and helped increase yields. Our highly active compounds can also be processed using this filter dryer with ancillary equipment, for customers that need additional protection for Occupational Exposure Limits (OELs),” stated Ted Dolan, Chief Operating Officer. “We are pleased to continue to offer more options for customers with our expanding capabilities.”
The DE Dietrich Agitated Filter Dryer also provides packaging efficiencies and the ability to re-dissolve using a second solvent within one system. The unit boasts a useful volume of 490 Liters, cake volume of 180 Liters and nominal filtration area of 0.6m2.
Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These “biologics” can be difficult to obtain and store on the battlefield or in remote areas. That’s why scientists are trying to develop portable systems that can quickly manufacture small batches of protein therapeutics on demand.READ MORE
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019